Related Experiment Videos

Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major

Blood
|January 1, 1986
PubMed

Insights

Peripheral blood monocytes in thalassemia major patients exhibit reduced lytic activity, not phagocytic activity. This defect, linked to iron overload, may increase infection risk in thalassemia major (ThP) patients.

Area of Science:

  • Immunology
  • Hematology

Background:

  • Thalassemia major (ThP) patients often experience increased susceptibility to infections.
  • The role of peripheral blood monocytes (PBMo) in the immune dysfunction of ThP is not fully understood.

Purpose of the Study:

  • To evaluate the phagocytic and lytic activities of PBMo in patients with thalassemia major.
  • To investigate the correlation between PBMo function and clinical parameters in ThP.

Main Methods:

  • Peripheral blood monocytes (PBMo) were isolated from patients with thalassemia major (ThP) and healthy controls.
  • Phagocytic and lytic activities of PBMo were assessed using Candida pseudotropicalis as the target organism.

Main Results:

  • PBMo from ThP patients demonstrated significantly decreased lytic activity compared to controls (P < .001).
  • Phagocytic activity of PBMo did not differ between ThP patients and controls.
  • Lytic activity showed significant inverse correlations with patient age (r² = .47; P < .01) and serum ferritin levels (r² = .65; P < .001).
  • No association was found between lytic activity and blood transfusion regimens, desferrioxamine therapy, liver damage, or hepatitis B surface antigen (sHBAg) presence.
  • Splenectomy did not improve PBMo function in ThP patients.

Conclusions:

  • Peripheral blood monocytes in thalassemia major patients possess an intracellular defect in microbicidal mechanisms, likely related to iron overload.
  • This PBMo dysfunction may contribute to the increased risk of infections observed in thalassemia major.
  • Therapeutic strategies targeting iron overload may be beneficial for improving immune function in ThP.

Related Concept Videos